Convelo Therapeutics to Develop New Regenerative Medicines for Neurological Disease Characterized by…
Convelo Therapeutics, Inc. announced that it has launched from stealth mode with a mission to discover and develop a new class of medicines that regenerate the protective myelin coating…
Read More...
Read More...
